医用射出成型市场－全球产业规模、份额、趋势、机会及预测（依材料、应用、机器类型、地区及竞争格局划分，2021-2031年）

全球医疗射出成型机市场预计将从 2025 年的 30.3 亿美元成长到 2031 年的 40.5 亿美元，复合年增长率为 4.95%。

这些专用机器旨在严格遵循卫生通讯协定，生产精密医用塑胶零件，通常在通过 ISO 认证的无尘室环境中运作。市场成长的主要驱动力是医疗耗材和医疗设备一次性使用需求的不断增长，这些产品需要大量、无菌生产，以最大限度地降低医疗环境中交叉感染的风险。此外，全球慢性病盛行率的上升和人口老化也使得复杂的药物输送系统亟需改进，而这又需要持续依赖先进的成型技术，以确保生物相容性和精确的规格。

然而，市场中存在许多障碍，包括经济的不确定性和所需的大量资本投资，这些都可能延缓采购决策。製造商需要根据市场需求的波动做出反应，这些波动会影响设备出货量。例如，塑胶工业协会报告称，2025年第三季北美射出成型机出货量较上季成长30.0%。这些资本设备投资的波动，通常由更广泛的经济困难所驱动，对医疗製造业产能的持续成长构成重大障碍。

市场驱动因素

严格的感染控制标准和广泛的自我给药疗法正在加速对一次性医疗耗材和器械的需求，这是市场成长的关键驱动因素。由于医疗机构优先使用无菌一次性产品以防止交叉感染，製造商正在扩大其大规模生产产品的产能，例如诊断试剂盒、自动注射器和预填充式注射器。这种消费激增直接促使製造商升级生产基础设施以满足生产目标。作为这一趋势的佐证，Gerresheimer AG 于 2025 年 2 月发布的 2024 年年度报告显示，其塑胶和器械部门实现了 11.413 亿欧元的收入，实现了 8.0% 的内部成长。这项业绩主要归功于对药物输送系统的强劲需求。

同时，医疗器材製造业正经历着向高精度全电动成型系统的重大转型，逐步取代液压系统。这些电动机器因其能源效率高、无需润滑油以及能够高重复性地成型复杂形状等优点，在无尘室环境中至关重要。这一趋势也体现在服务于医疗器材产业的主要设备製造商近期的财务表现。例如，发那科公司（FANUC Corporation）于2025年2月发布的截至2024年12月31日的九个月财务报告中显示，由于Roboshot电机订单增加，其机器人设备部门的净销售额增长了21.8%。海天国际在2025年发布的报告也印证了这项全球需求的强劲，其2024财年的年收入成长了23.4%，达到人民币161亿元。

市场挑战

高昂的资本投资成本和经济波动是限制全球医用射出成型机市场持续扩张的主要障碍。由于医疗器材製造需要昂贵且高精度的设备来满足严格的监管要求，采购决策对金融市场的不稳定性高度敏感。在经济不确定性和高利率时期，製造商往往会推迟资本投资以保护现金流并降低财务风险。这种犹豫不决导致设备供应商的订单量波动，阻碍了产能的稳定扩张，无法满足日益增长的医疗耗材需求。

近期产业数据显示，设备采购量出现剧烈波动，印证了市场的这种不稳定性。美国塑胶工业协会 (PIA) 报告称，2025 年第一季北美射出成型机出货量较上月下降 21.8%。这一急剧下滑（儘管此后有所回升）表明，经济困难会导致投资即时减少。这种不确定性使得医疗设备製造商难以长期规划，迫使他们不断调整产能扩大策略以适应不断变化的经济环境，而非着眼于长期的医疗需求。

市场趋势

智慧製造和工业4.0技术的应用正在从根本上改变医疗产业的生产通讯协定，使其从基本的机器操作演变为完全整合、智慧化的生态系统。製造商正在加速实施即时製程监控和预测维修系统，以确保关键医疗组件所需的零缺陷质量，并降低监管风险和停机时间。向数位自动化转型对于最大限度地提高资源效率，同时保持洁净室环境所需的严格标准至关重要。市场对这些先进功能的需求也反映在近期的各项指标中。例如，恩格尔集团在2025年5月的新闻稿中表示，儘管全球投资放缓，但在2024/25财年的销售额仍将达到约15亿欧元，并透过自动化创新扩大了市场份额。

同时，在单一生产週期内生产复杂的多组件医疗设备的需求，正推动多射多成分注塑成型技术的市场显着成长。这一趋势在诊断工具和药物输送系统的生产中尤其明显，这些产品需要将刚性结构件与柔软的密封手柄整合在一起，且无需二次组装，以最大限度地降低污染风险。设备供应商正积极拓展产品线，透过技术升级和策略性收购来支援这些复杂的多材料应用。例如，《加拿大现代塑胶》杂誌在2025年3月报道称，Husky Technologies收购了MGS Healthcare Manufacturing的旋转压板和二次注塑单元技术，直接增强了其面向医疗产业的整合多材料解决方案组合。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球医用射出成型机市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依材料分类（聚丙烯、聚乙烯、热可塑性橡胶、环烯烃共聚物、丙烯腈-丁二烯-苯乙烯共聚物、其他）
  • 依应用领域（外科手术、製药、诊断、医疗设备、医疗保健、化妆品）
  • 依机器类型（标准射出成型机、多成分射出成型机、LSR射出成型机）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美医用射出成型机市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

第七章 欧洲医用射出成型机市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章 亚太地区医用射出成型市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲医疗射出成型市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲医用射出成型机市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球医用射出成型机市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Hillenbrand, Inc.
• WITTMANN Technology GmbH
• UBE Machinery Inc.
• KraussMaffei Group
• Japan Steel Works, Ltd.
• AMS Micromedical, LLC.
• Proto Labs, Inc.
• Sumitomo（SHI）Demag Plastics Machinery GmbH
• Milacron LLC
• ENGEL AUSTRIA GmbH

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Medical Injection Molding Machines Market is projected to expand from USD 3.03 Billion in 2025 to USD 4.05 Billion by 2031, reflecting a CAGR of 4.95%. These specialized machines are designed to manufacture precise, medical-grade plastic parts within strict hygiene protocols, often functioning in ISO-certified cleanroom settings. The market's upward trajectory is largely sustained by the growing need for single-use medical consumables and devices, which demand high-volume, sterile production to minimize cross-contamination risks in healthcare environments. Additionally, the increasing global burden of chronic illnesses and an aging demographic necessitate sophisticated drug delivery systems, ensuring a continuous reliance on advanced molding technologies that guarantee biocompatibility and precise specifications.

However, the market encounters substantial hurdles due to economic instability and substantial capital investment requirements, factors that can postpone purchasing decisions. This volatility impacts equipment shipment volumes as manufacturers adapt to fluctuating market demands. For instance, the Plastics Industry Association reported that injection molding shipments in North America increased by 30.0 percent in the third quarter of 2025 relative to the prior quarter. Such oscillations in capital equipment spending, frequently driven by wider economic difficulties, pose a significant barrier to the consistent growth of production capacity within the medical manufacturing industry.

Market Driver

The accelerating demand for single-use medical consumables and devices acts as a primary engine for market growth, driven by rigorous infection control standards and the spread of self-administered drug therapies. As healthcare institutions prioritize disposable, sterile products to reduce cross-contamination, manufacturers are increasing their capacity for high-volume items like diagnostic cartridges, auto-injectors, and prefilled syringes. This consumption spike directly requires upgraded manufacturing infrastructure to achieve production goals. Evidence of this trend is found in Gerresheimer AG's 'Annual Report 2024' from February 2025, which noted that their Plastics & Devices Division achieved EUR 1,141.3 million in revenue with 8.0% organic growth, a performance specifically attributed to the robust demand for drug delivery systems.

Concurrently, the industry is experiencing a vital shift toward high-precision all-electric molding systems, which are steadily superseding hydraulic models in medical production. These electric machines are essential for cleanroom environments because of their energy efficiency, oil-free operation, and capacity to mold complex shapes with high repeatability. This trend is reflected in the recent financial results of leading equipment providers who are catering to the medical sector's needs. For example, Fanuc Corporation's February 2025 report on results for the nine months ending December 31, 2024, showed a 21.8% rise in net sales for its Robomachine division, bolstered by Roboshot electric machine orders. Highlighting the magnitude of this global demand, Haitian International reported in 2025 that its annual revenue for the 2024 fiscal year grew by 23.4% to RMB 16.1 billion.

Market Challenge

High capital investment costs and economic volatility pose major obstacles to the consistent expansion of the Global Medical Injection Molding Machines Market. Because medical manufacturing necessitates expensive, high-precision machinery to adhere to stringent regulatory mandates, procurement choices are extremely susceptible to financial instability. In periods of economic uncertainty or high interest rates, manufacturers frequently delay capital expenditures to protect cash flow and reduce financial exposure. This hesitation leads to fluctuating order volumes for machinery vendors, hindering the steady scaling of production capacities required to satisfy the growing demand for medical consumables.

Recent industrial data regarding severe swings in equipment acquisition confirms this market instability. The Plastics Industry Association reported that North American shipments of injection molding machinery dropped by 21.8 percent in the first quarter of 2025 compared to the preceding quarter. This sharp decline, which occurred before a later recovery, illustrates how economic difficulties trigger immediate contractions in investment. Such unpredictability makes long-term planning difficult for medical device manufacturers, forcing them to constantly adapt their capacity expansion strategies to fit changing financial conditions rather than addressing long-term healthcare requirements.

Market Trends

The adoption of smart manufacturing and Industry 4.0 technologies is fundamentally transforming production protocols in the medical sector, advancing from basic machine operations to fully integrated, intelligent ecosystems. Manufacturers are increasingly implementing real-time process monitoring and predictive maintenance systems to guarantee the zero-defect quality essential for critical medical parts, thereby reducing regulatory risks and downtime. This move toward digital automation is crucial for upholding the rigorous standards needed in cleanroom settings while maximizing resource efficiency. The market appetite for these advanced capabilities is reflected in recent metrics; for instance, the Engel Group reported in a May 2025 press release that it achieved a turnover of roughly EUR 1.5 billion for the 2024/25 financial year, successfully growing its market share through automation innovations despite a global dip in investment.

At the same time, the market is seeing significant growth in multi-shot and multi-component molding capabilities, spurred by the requirement to fabricate complex, composite medical devices within a single manufacturing cycle. This trend is especially common in the production of diagnostic tools and drug delivery systems, where rigid structural components must be integrated with soft-touch seals and grips without secondary assembly to minimize contamination risks. Equipment suppliers are actively broadening their offerings to support these complex multi-material applications through technological upgrades and strategic acquisitions. Highlighting this direction, Modern Plastics Canada reported in March 2025 that Husky Technologies acquired rotary platen and secondary injection unit technologies from MGS Healthcare Manufacturing to directly bolster its portfolio of integrated multi-material solutions for the medical industry.

Key Market Players

• Hillenbrand, Inc.
• WITTMANN Technology GmbH
• UBE Machinery Inc.
• KraussMaffei Group
• Japan Steel Works, Ltd.
• AMS Micromedical, LLC.
• Proto Labs, Inc.
• Sumitomo (SHI) Demag Plastics Machinery GmbH
• Milacron LLC
• ENGEL AUSTRIA GmbH

Report Scope

In this report, the Global Medical Injection Molding Machines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medical Injection Molding Machines Market, By Material

• Polypropylene
• Polyethylene
• Thermoplastic Elastomer
• Cyclic Olefin Copolymer
• Acrylonitrile Butadiene Styrene
• Others

Medical Injection Molding Machines Market, By Application

• Surgery
• Pharma
• Diagnostics
• Medical Equipment
• Healthcare
• Cosmetics

Medical Injection Molding Machines Market, By Machine Type

• Standard Injection Molding Machine
• Multi-component Injection Molding Machine
• LSR Injection Molding Machine

Medical Injection Molding Machines Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medical Injection Molding Machines Market.

Available Customizations:

Global Medical Injection Molding Machines Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medical Injection Molding Machines Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Material (Polypropylene, Polyethylene, Thermoplastic Elastomer, Cyclic Olefin Copolymer, Acrylonitrile Butadiene Styrene, Others)
  • 5.2.2. By Application (Surgery, Pharma, Diagnostics, Medical Equipment, Healthcare, Cosmetics)
  • 5.2.3. By Machine Type (Standard Injection Molding Machine, Multi-component Injection Molding Machine, LSR Injection Molding Machine)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Medical Injection Molding Machines Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Material
  • 6.2.2. By Application
  • 6.2.3. By Machine Type
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Medical Injection Molding Machines Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Material
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Machine Type
  • 6.3.2. Canada Medical Injection Molding Machines Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Material
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Machine Type
  • 6.3.3. Mexico Medical Injection Molding Machines Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Material
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Machine Type

7. Europe Medical Injection Molding Machines Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Material
  • 7.2.2. By Application
  • 7.2.3. By Machine Type
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Medical Injection Molding Machines Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Material
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Machine Type
  • 7.3.2. France Medical Injection Molding Machines Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Material
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Machine Type
  • 7.3.3. United Kingdom Medical Injection Molding Machines Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Material
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Machine Type
  • 7.3.4. Italy Medical Injection Molding Machines Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Material
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Machine Type
  • 7.3.5. Spain Medical Injection Molding Machines Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Material
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Machine Type

8. Asia Pacific Medical Injection Molding Machines Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Material
  • 8.2.2. By Application
  • 8.2.3. By Machine Type
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Medical Injection Molding Machines Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Material
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Machine Type
  • 8.3.2. India Medical Injection Molding Machines Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Material
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Machine Type
  • 8.3.3. Japan Medical Injection Molding Machines Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Material
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Machine Type
  • 8.3.4. South Korea Medical Injection Molding Machines Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Material
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Machine Type
  • 8.3.5. Australia Medical Injection Molding Machines Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Material
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Machine Type

9. Middle East & Africa Medical Injection Molding Machines Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Material
  • 9.2.2. By Application
  • 9.2.3. By Machine Type
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Medical Injection Molding Machines Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Material
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Machine Type
  • 9.3.2. UAE Medical Injection Molding Machines Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Material
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Machine Type
  • 9.3.3. South Africa Medical Injection Molding Machines Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Material
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Machine Type

10. South America Medical Injection Molding Machines Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Material
  • 10.2.2. By Application
  • 10.2.3. By Machine Type
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Medical Injection Molding Machines Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Material
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Machine Type
  • 10.3.2. Colombia Medical Injection Molding Machines Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Material
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Machine Type
  • 10.3.3. Argentina Medical Injection Molding Machines Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Material
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Machine Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Medical Injection Molding Machines Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Hillenbrand, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. WITTMANN Technology GmbH
• 15.3. UBE Machinery Inc.
• 15.4. KraussMaffei Group
• 15.5. Japan Steel Works, Ltd.
• 15.6. AMS Micromedical, LLC.
• 15.7. Proto Labs, Inc.
• 15.8. Sumitomo (SHI) Demag Plastics Machinery GmbH
• 15.9. Milacron LLC
• 15.10. ENGEL AUSTRIA GmbH

16. Strategic Recommendations

17. About Us & Disclaimer